东方嘉盛：10月24日召开董事会会议

Group 1 - The core point of the article is that Dongfang Jiasheng (SZ 002889) held its seventh board meeting on October 24, 2025, to review the proposal for the third quarter report of 2025 [1] - For the first half of 2025, Dongfang Jiasheng's revenue composition shows that supply chain management services accounted for 99.88%, while other businesses made up 0.12% [1] - As of the report date, Dongfang Jiasheng has a market capitalization of 5.7 billion yuan [1] Group 2 - The article mentions that the Chinese innovative drug sector has sold overseas authorizations worth 80 billion USD this year [1] - There is a discussion on the hot secondary market for biomedicine, while the primary market is facing challenges in fundraising [1]